It’s been more than a month since the Food and Drug Administration officially announced the rule, but you still have time to get your hands on some edibles.
The agency has just announced that it will begin issuing the first permits to manufacturers for the new recreational marijuana edibles in February.
The FDA will allow manufacturers to produce up to 12,500 joints per day.
Manufacturers will also be allowed to sell up to six grams of marijuana per person, and the agency will require the product to be kept in a secure, locked, and labeled container.
The rules also include requirements for labeling, labelling, and testing for potency, and require the company to post a public warning about the risk of ingesting or inhaling marijuana.
The announcement was made in a press release by the FDA, and it goes on to say that the rules will help provide clarity and safety for consumers who may not know about how marijuana is processed, packaged, and distributed.
“As this new product has become more popular, there have been reports of users being unaware of the potential dangers and risks of the cannabis,” said Michael D. Hartman, the acting assistant commissioner for the FDA.
“We hope the rules provide clarity on the risks of marijuana consumption, while also helping consumers to make informed decisions about their cannabis consumption.”
These regulations were a direct response to the federal government’s decision to remove cannabis from Schedule 1 of the Controlled Substances Act, which is a classification that basically means it’s not a controlled substance.
In 2018, the DEA proposed to remove the drug from Schedule 2, which includes hashish, marijuana, and cocaine.
The rule change was a response to a new scientific study that suggested the drugs’ effects on the central nervous system and cardiovascular system are very similar to marijuana.
As such, the federal Department of Health and Human Services, or DHHS, announced it was removing marijuana from Schedule II, making it more closely tied to heroin.
The government, however, did not actually put cannabis in Schedule I. So the FDA will be taking it up on its own.
It will still be a little bit of a road ahead, as it still requires manufacturers to submit an application to the agency, which will then go to the Department of Justice.
The new rules come just two months after President Donald Trump signed a bill repealing the federal ban on marijuana.
However, it is important to note that marijuana remains illegal under federal law.
The DEA has already stated that marijuana will remain a Schedule 1 drug until at least 2020, but it’s unlikely that the administration will go that far before Trump leaves office.